Curet Myriam - Nov 12, 2024 Form 4 Insider Report for INTUITIVE SURGICAL INC (ISRG)

Role
EVP & Chief Medical Officer
Signature
By: Donna Spinola For: Curet, Myriam
Stock symbol
ISRG
Transactions as of
Nov 12, 2024
Transactions value $
-$4,559,196
Form type
4
Date filed
11/13/2024, 04:21 PM
Previous filing
Jul 24, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ISRG Common Stock Options Exercise $402K +2.26K +757.38% $177.99 2.56K Nov 12, 2024 Direct F1
transaction ISRG Common Stock Sale -$1.21M -2.26K -88.34% $535.96 298 Nov 12, 2024 Direct F1, F2
transaction ISRG Common Stock Options Exercise $914K +5K +1677.85% $182.83 5.3K Nov 12, 2024 Direct F1
transaction ISRG Common Stock Sale -$2.68M -5K -94.38% $535.96 298 Nov 12, 2024 Direct F1, F2
transaction ISRG Common Stock Options Exercise $504K +2.2K +737.92% $229.39 2.5K Nov 12, 2024 Direct F1
transaction ISRG Common Stock Sale -$1.18M -2.2K -88.07% $535.96 298 Nov 12, 2024 Direct F1, F2
transaction ISRG Common Stock Options Exercise $838K +4.01K +1345.64% $208.90 4.31K Nov 12, 2024 Direct F1
transaction ISRG Common Stock Sale -$2.15M -4.01K -93.08% $535.96 298 Nov 12, 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -2.26K -100% $0.00 0 Nov 12, 2024 Common Stock 2.26K $177.99 Direct F1, F3
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -5K -100% $0.00 0 Nov 12, 2024 Common Stock 5K $182.83 Direct F1, F3
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -4.01K -66.67% $0.00 2.01K Nov 12, 2024 Common Stock 4.01K $208.90 Direct F1, F4
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -2.2K -43.74% $0.00 2.83K Nov 12, 2024 Common Stock 2.2K $229.39 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 13, 2025.
F2 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $533.10 to $538.66 as follows: 4,510 shares sold at $533.10 to $534.07; 907 shares sold at $534.11 to $534.68; 200 shares sold at $535.34 to $536.28; 4,400 shares sold at $536.46 to $537.36; 3,437 shares sold at $537.49 to $538.36; and 12 shares sold at $538.66. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3 Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.
F4 Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.
F5 12.5% of the shares subject to the option vest on the six-month anniversary measured from February 10, 2023, and 1/48th of the total number of shares vest in forty-two (42) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date.